IPSEN BIOPHARM PATENTS FACING OPPOSITIONS
Top patents of IPSEN BIOPHARM facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3266456B1 | 05 May, 2021 | Combinations Of Liposomal Irinotecan, 5-Fu And Leucovorin For The Treatment Of Pancreatic Cancer | Jun, 2033 | 3 | |
| EP3337478B1 | 12 Aug, 2020 | Methods For Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan And Oxaliplatin | Aug, 2036 | 2 | |
| EP3337467B1 | 09 Dec, 2020 | Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment | Aug, 2036 | 1 | |
| EP2939688B1 | 20 Feb, 2019 | Pharmaceutical Compositions Comprising Botulinum Neurotoxin | NA | 1 |